356 related articles for article (PubMed ID: 37101167)
21. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
Ork V; Woodring J; Shafiqul Hossain M; Wasley A; Nagashima S; Yamamoto C; Chuon C; Sugiyama A; Ohisa M; Akita T; Ko K; Mao B; Tanaka J
Vaccine; 2019 Aug; 37(35):5059-5066. PubMed ID: 31285088
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
[TBL] [Abstract][Full Text] [Related]
23. Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018.
Breakwell L; Marke D; Kaiser R; Tejada-Strop A; Pauly MD; Jabbi S; Yambasu S; Kabore HJ; Stewart B; Sesay T; Samba TT; Hayden T; Kamili S; Jambai A; Drobeniuc J; Singh T; Tohme RA; Wasley A
Vaccine; 2022 Apr; 40(19):2741-2748. PubMed ID: 35361502
[TBL] [Abstract][Full Text] [Related]
24. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China.
Chen T; Wang J; Qiu H; Yu Q; Yan T; Qi C; Cao F; Tian Z; Guo D; Yao N; Yang Y; He Y; Zhao Y; Liu J
Medicine (Baltimore); 2018 Jul; 97(27):e11406. PubMed ID: 29979437
[TBL] [Abstract][Full Text] [Related]
25. Risk of mother-to-child transmission of hepatitis B virus after fetal blood sampling: a report of six cases.
Han Z; Zhang Y; Zhou J; Wang Q; Huang Y; Hou H
BMC Infect Dis; 2021 Jul; 21(1):716. PubMed ID: 34330230
[TBL] [Abstract][Full Text] [Related]
26. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
[TBL] [Abstract][Full Text] [Related]
27. Prevalence, Infectivity, and Associated Risk Factors of Hepatitis B Virus among Pregnant Women in Yirgalem Hospital, Ethiopia: Implication of Screening to Control Mother-to-Child Transmission.
Amsalu A; Ferede G; Eshetie S; Tadewos A; Assegu D
J Pregnancy; 2018; 2018():8435910. PubMed ID: 30174956
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of hepatitis B among childbearing women and infant born to HBV-positive mothers in Togo.
Ekouevi DK; Larrouy L; Gbeasor-Komlanvi FA; Mackiewicz V; Tchankoni MK; Bitty-Anderson AM; Gnatou GY; Sadio A; Salou M; Dagnra CA; Descamps D; Coffie PA
BMC Infect Dis; 2020 Nov; 20(1):839. PubMed ID: 33183254
[TBL] [Abstract][Full Text] [Related]
29. Intermediate hepatitis B virus infection prevalence among 1622 pregnant women in rural Burkina Faso and implications for mother-to-child transmission.
Ouoba S; Ko K; Lingani M; Nagashima S; Guingané AN; Bunthen E; Hussain MRA; Sugiyama A; Akita T; Ohisa M; Sanou MA; Traore O; Nassa JW; Sanou M; Takahashi K; Tinto H; Tanaka J
Sci Rep; 2023 Apr; 13(1):6115. PubMed ID: 37059812
[TBL] [Abstract][Full Text] [Related]
30. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
31. Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.
Tamandjou Tchuem CR; Andersson MI; Wiysonge CS; Mufenda J; Preiser W; Cleary S
Vaccine; 2021 May; 39(23):3141-3151. PubMed ID: 33962836
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study.
Ségéral O; N'Diaye DS; Prak S; Nouhin J; Chhun S; Khamduang W; Chim K; Roque-Afonso AM; Piola P; Borand L; Ngo-Giang-Huong N; Rouet F;
J Clin Virol; 2018 Dec; 109():29-34. PubMed ID: 30388664
[TBL] [Abstract][Full Text] [Related]
33. Outcome of Infants Born to Women with Chronic Hepatitis B: A Local Risk-Based Strategy in a Low Prevalence Country.
Copiz GI; Ibañez C; Piñera C; Cordova L; Payá E; Leal P; Villena R
Matern Child Health J; 2024 Apr; 28(4):767-774. PubMed ID: 38358537
[TBL] [Abstract][Full Text] [Related]
34. Increased Protection of Earlier Use of Immunoprophylaxis in Preventing Perinatal Transmission of Hepatitis B Virus.
Huang H; Xu C; Liu L; Chen L; Zhu X; Chen J; Feng J; Chen T; Xu B; Yang J; Xu B; Pan M; Dai Y; Hu Y; Zhou YH
Clin Infect Dis; 2021 Nov; 73(9):e3317-e3323. PubMed ID: 32634824
[TBL] [Abstract][Full Text] [Related]
35. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
[TBL] [Abstract][Full Text] [Related]
36. Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province, China.
Kang W; Ding Z; Shen L; Zhao Z; Huang G; Zhang J; Xiong Q; Zhang S; Zhang S; Wang F
Vaccine; 2014 Jun; 32(27):3362-6. PubMed ID: 24793939
[TBL] [Abstract][Full Text] [Related]
37. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P
Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689
[TBL] [Abstract][Full Text] [Related]
38. A cautionary note to hepatitis B e antigen (HBeAg)-negative test results in pregnant women in an area prevalent of HBeAg-negative chronic hepatitis B.
Chalid MT; Turyadi ; Ie SI; Sjahril R; Wahyuni R; Nasrum Massi M; Muljono DH
J Med Virol; 2023 Jan; 95(1):e28125. PubMed ID: 36064856
[TBL] [Abstract][Full Text] [Related]
39. Breast feeding and immunoprophylaxis efficacy of mother-to-child transmission of hepatitis B virus.
Zhang L; Gui X; Fan J; Wang B; Ji H; Yisilafu R; Li F; Zhou Y; Tong Y; Kong X; Ye P; Zong L
J Matern Fetal Neonatal Med; 2014 Jan; 27(2):182-6. PubMed ID: 23682864
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
